| Jul 16 |
Is Caribou Biosciences (NASDAQ:CRBU) In A Good Position To Deliver On Growth Plans?
|
| Jul 9 |
Caribou Biosciences Announces Appointment of Terri Laufer, MD, to its Scientific Advisory Board
|
| Jul 5 |
Caribou's Allogeneic CAR-T Therapy: Analyzing HLA Matching And CB-010's Clinical Performance
|
| Jul 3 |
Caribou Biosciences: Promising Gene Editing Therapies With Strong Buy Potential
|
| Jun 4 |
Cracking The Code: Understanding Analyst Reviews For Caribou Biosciences
|
| Jun 3 |
Top Midday Decliners
|
| Jun 3 |
Caribou stock plunges 30% amid study update, Evercore downgrade
|
| Jun 2 |
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
|
| May 30 |
Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor Conferences
|
